Annual Accounts Payable
$479.00 K
-$122.00 K-20.30%
December 31, 2024
Summary
- As of February 26, 2025, MLYS annual accounts payable is $479.00 thousand, with the most recent change of -$122.00 thousand (-20.30%) on December 31, 2024.
- During the last 3 years, MLYS annual accounts payable has fallen by -$284.00 thousand (-37.22%).
- MLYS annual accounts payable is now -74.88% below its all-time high of $1.91 million, reached on December 31, 2022.
Performance
MLYS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$479.00 K
-$2.63 M-84.58%
December 31, 2024
Summary
- As of February 26, 2025, MLYS quarterly accounts payable is $479.00 thousand, with the most recent change of -$2.63 million (-84.58%) on December 31, 2024.
- Over the past year, MLYS quarterly accounts payable has dropped by -$122.00 thousand (-20.30%).
- MLYS quarterly accounts payable is now -91.40% below its all-time high of $5.57 million, reached on September 30, 2023.
Performance
MLYS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MLYS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.3% | -20.3% |
| 3 y3 years | -37.2% | -20.3% |
| 5 y5 years | -9.4% | -20.3% |
MLYS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.9% | at low | -91.4% | at low |
| 5 y | 5-year | -74.9% | at low | -91.4% | at low |
| alltime | all time | -74.9% | at low | -91.4% | at low |
Mineralys Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $479.00 K(-20.3%) | $479.00 K(-84.6%) |
| Sep 2024 | - | $3.11 M(+82.0%) |
| Jun 2024 | - | $1.71 M(-59.9%) |
| Mar 2024 | - | $4.26 M(+609.0%) |
| Dec 2023 | $601.00 K | $601.00 K(-89.2%) |
| Sep 2023 | - | $5.57 M(+153.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $2.20 M(-8.0%) |
| Mar 2023 | - | $2.39 M(+25.2%) |
| Dec 2022 | $1.91 M(+149.9%) | $1.91 M(-25.6%) |
| Sep 2022 | - | $2.56 M(+235.9%) |
| Dec 2021 | $763.00 K(+44.2%) | - |
| Dec 2021 | - | $763.00 K |
| Dec 2020 | $529.00 K | - |
FAQ
- What is Mineralys Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual accounts payable year-on-year change?
- What is Mineralys Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly accounts payable year-on-year change?
What is Mineralys Therapeutics annual accounts payable?
The current annual accounts payable of MLYS is $479.00 K
What is the all time high annual accounts payable for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual accounts payable is $1.91 M
What is Mineralys Therapeutics annual accounts payable year-on-year change?
Over the past year, MLYS annual accounts payable has changed by -$122.00 K (-20.30%)
What is Mineralys Therapeutics quarterly accounts payable?
The current quarterly accounts payable of MLYS is $479.00 K
What is the all time high quarterly accounts payable for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly accounts payable is $5.57 M
What is Mineralys Therapeutics quarterly accounts payable year-on-year change?
Over the past year, MLYS quarterly accounts payable has changed by -$122.00 K (-20.30%)